(Q44744869)
English
Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising prostate-specific antigen level after hormonal therapy for pr
scientific article published in December 2003
Statements
1 reference
Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising prostate-specific antigen level after hormonal therapy for pr (English)
1 reference
Michael A Carducci
1 reference
Janet R Walczak
1 reference
Eastern Cooperative Oncology Group E1899
1 reference
1 December 2003
1 reference
1 reference
62 Suppl 1
1 reference
141-146
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference